Prof Driss Jamil
Prof Jamil is a specialist in hepatitis B and C epidemiology at the Department of Medicine, University of Casablanca, Morocco. He is a former Director of the Moroccan National Hospital and the founder of Fédération SOS Hépatites in Morocco, which aims to support patients with hepatitis. In 2005, SOS Hépatites led the establishment of the Maghreb Hepatitis Forum, in collaboration with similar patient groups in Algeria and Tunisia. In October 2007, the creation of the Foundation SOS Hépatites Maghreb was announced and includes representatives from Morocco, Algeria, Tunisia and Libya in order to unify the fight against Hepatitis in North Africa. Prof. Jamil’s ongoing research focuses on the hepatitis B and C viruses and access to diagnosis and treatment in North Africa.
|
Prof Gamal Esmat
Prof Esmat is Professor of Hepatology & Tropical Medicine, and Director of the Schistosomal Liver Unit at the Faculty of Medicine, Cairo University , Egypt. He is the current President of International Association for the Study of the Liver (IASL). His ongoing research projects include the epidemiology of HCV in Egyptian children for which he is the Principle Investigator and the treatment of HCV genotype 4 patients and noninvasive markers for detection of hepatic fibrosis.
|
Prof Jean-Michel Pawlotsky
Dr Pawlotsky is Professor of Medicine at the University of Paris XII and Director of the Department of Virology and of the French National Reference Centre for Viral hepatitis B, C and D at the Henri Mondor University Hospital. In addition to being the Secretary General of the European Association for the Study of the Liver (EASL), Dr. Pawlotsky is a member of the Scientific College of the French National Agency for AIDS and Viral Hepatitis Research (ANRS).
|
Prof Hui Zhuang
Prof Zhuang is currently a Professor at the Department of Microbiology, Peking University Health Science Centre, China. He is the Honorary Chairman of the Chinese Society of Hepatology and a member of the WHO Regional Commission for Certification of Poliomyelitis Eradication in Western Pacific. He also serves on the Expert Advisory Committee on Viral Hepatitis for the Chinese Ministry of Health. He is a member of Chinese Academy of Engineering, which is the highest academic title and a life-long honour.
|
Prof Baruch Blumberg
Prof Blumberg was awarded the Nobel Prize in 1976 for "discoveries concerning new mechanisms for the origin and dissemination of infectious diseases" and specifically, for the discovery of the hepatitis B virus. In 1993, he was elected to the National Inventors Hall of Fame for the invention of the hepatitis B vaccine and the diagnostic test for hepatitis B. Prof Blumberg currently holds the post of Distinguished Scientist at the Fox Chase Cancer Center, Philadelphia, Professor of Medicine and Anthropology at the University of Pennsylvania, and President of the American Philosophical Society, USA.
|
Prof Greg Dore
Professor Gregory Dore is Head of the Viral Hepatitis Clinical Research Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales and an Infectious Diseases Physician at St Vincent's Hospital, Sydney, Australia. He has been involved in the areas of viral hepatitis and HIV for many years, in academic research, clinical, and public health policy capacities. Professor Dore is a member of various public health advisory boards and Vice-President of the Australasian Society for HIV Medicine.
|
Dr Miguel Garassini
Prof Garassini is Professor of Clinical Gastroenterology at the “Luis Razzetti” School of Venezuela’s Central University and is also affiliated with Gastroenterology Services at University Hospital, Caracas. He is currently President of the Latin American Association for the Study of the Liver (ALEH) and an active member of the Venezuelan Gastroenterology Society (SVG), the American Gastroenterological Association (AGA) and the American Association for the Study of the Liver (AASLD). Prof Garassini is also Associate Editor of GEN, the offical journal of the Venezuelan Gastroenterology Society and is a member of the Editorial Board of the Annals of Hepatology, the oficial journal of the Mexican Hepatology Association.
|
Dr João Silvia de Mendonça
Dr Mendonça is Director of the Infectious Diseases Service, Hospital do Servidor Público Estadual de São Paulo, Brazil. He is currently the Scientific Coordinator of the Brazilian Society of Infectious Diseases (2008-09) and a member of the Advisory Committee of the National Program on Viral Hepatitis, Health Surveillance Secretary, Ministry of Health, Brazil. He is also a member of the Advisory Committee of the Immunization Division, São Paulo State Secretary of Health.
|
Prof S P Singh
Prof Singh is the Head of the Department of Gastroenterology at the S.C.B. Medical College, India. He is founder of the Kalinga Gastroenterology Foundation and Hepatitis B Eradication Day. In 2004, he launched the free access journal Hepatitis B Annual dedicated to dissemination of knowledge about Hepatitis B amongst the medical fraternity of the developing world. He was a member of the 2007 World Digestive Health Day Committee of the World Gastroenterology Organisation [WGO].
|
Prof Stefan Zeuzem
Prof Zeuzem is Professor of Medicine and Chief of the Department of Medicine, at the J.W. Goethe University Hospital, Frankfurt, Germany. Professor Zeuzem is a member of numerous professional associations and has co-authored manuscripts, book chapters and reviews encompassing varied aspects of internal medicine. His current research interests include cellular physiology, molecular biology of hepatitis viruses, viral kinetics, the role of hepatitis C in hepatocarcinogenesis, and the stratification and optimization of antiviral treatment.
|
Prof Mohammad Ali
Prof Mohammad Ali is the Head of the Department of Hepato-Biliary-Pancreatic Surgery & Liver Transplant Services of BIRDEM Hospital, Dhaka, Bangladesh. Prof Ali is also the founding Secretary General of the Liver Foundation of Bangladesh, a philanthropic organisation and centre of excellence for liver diseases in Bangladesh. He is a fellow in Hepato-Biliary-Pancreatic and Liver transplant Surgery of Queensland Liver Transplant Services, Queensland University, Australia.
|
Dr Michael Houghton
Dr. Houghton and his colleagues at the Chiron Corporation and the CDC were the first to identify the hepatitis C virus and prove it to be the major agent of blood-borne Non-A, Non-B hepatitis around the world. The team went on to develop blood tests for hepatitis C that are now used across the globe to diagnose infected patients and prevent transfusion-associated hepatitis C infection. Their groundbreaking work in identifying the hepatitis C virus genome has also facilitated new strategies in developing specific drugs and vaccines to control hepatitis C infection and disease. Dr. Houghton is currently Chief Scientific Officer at Epiphany Biosciences Inc. in San Francisco where his work on hepatitis C continues, along with the study of other viral pathogens.
|